Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$1.09 - $2.04 $218 - $408
200 New
200 $0
Q2 2022

Aug 11, 2022

BUY
$1.39 - $3.12 $278 - $624
200 New
200 $0
Q1 2022

Apr 29, 2022

SELL
$2.6 - $4.17 $520 - $834
-200 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$3.64 - $7.78 $728 - $1,556
200 New
200 $1,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.